Intellectual Property India Publishes Patent Application for 'Salt-Type Glp-1 Receptor Agonist, Crystal Form Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof, And Use Thereof' Filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517064696 A) filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd., Zhejiang, China, on July 7, for 'salt-type glp-1 receptor agonist, crystal form thereof, preparation method therefor, pharmaceutical composition thereof, and use thereof.'

Inventor(s) include Zhai, Wenqiang; Tan, Fang; Han, Min; Pan, Hao; and Liu, Dongzhou.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "Disclosed are a salt-type GLP-1 receptor agonist, a crystal form thereof, a preparation method therefor, a pharmaceutical composition thereof, and the use thereof. Specifically, the GLP-1 receptor agonist is (S)-2-((4-(6-((2-fluoro-4-(oxetane-3-yl)benzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(oxetane-2-ylmethyl)-1H-benzo[d]imidazole-6-carboxylic acid."

The patent application was internationally filed on Dec. 11, 2023, under International application No.PCT/CN2023/137851.

Disclaimer: Curated by HT Syndication.